维百奥生物代理Doron scientific品牌全系列产品
Doron scientific 专注于向制药、生物技术、诊断和学术研究人员供应研究和诊断、免疫学和分子生物学产品。Doron scientific供应细胞培养与蛋白质、分子生物学、兽医学、信号转导、细胞生物学、缓冲液与溶液、免疫分析试剂盒、抗体、ELISA 试剂盒以及各种其他产品。
▍Doron scientific部分产品列表
| 品名 | 货号 | 规格 |
| Anti-Adalimumab Antibodies (AY23b) (recommended for PK/PD) | ADB-Y23b | 1mg |
| Anti-Rituximab Antibodies (MALS verified) | RIB-Y35c | 1mg |
| Anti-Trastuzumab Antibodies (AY1b) (recommended for PK/PD) | TRB-Y1b | 1mg |
| Rabbit Anti-Mouse FMC63 scFv Polyclonal Antibody (recommended for ADA assay) (MALS verified) | FM3-S93 | 1mg |
| Anti-Rituximab Antibodies (AY37) (recommended for PK/PD) | RIB-Y37 | 1mg |
| Anti-Bevacizumab Antibodies (AY10) (MALS verified, recommended for PK/PD) | BEB-Y10 | 1mg |
| Anti-Cetuximab Antibodies (AY29) (recommended for PK/PD) | CEB-Y29 | 1mg |
| Anti-Rituximab Antibodies | RIB-Y35 | 1mg |
| Anti-Rituximab Antibodies (AY36) (recommended for ADA assay) | RIB-Y36 | 1mg |
| Anti-Trastuzumab Antibodies (recommended for PK/PD) | TRB-Y1 | 1mg |
| Biotinylated Anti-Bevacizumab Antibodies (AY13) (recommended for PK/PD) | BEB-BY13 | 200ug |
| Anti-Trastuzumab Antibodies (AY5b) (recommended for PK/PD) | TRB-Y5b | 1mg |
| Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (Carrier-free) (recommended for ADA assay) DMF Filed | FM3-Y45A1 | 1mg |
| Anti-Cetuximab Antibodies (AY28) | CEB-Y28 | 1mg |
| Anti-Cetuximab Antibodies (AY27) (recommended for ADA assay) | CEB-Y27 | 1mg |
| Biotinylated Anti-Cetuximab Antibodies (AY31) (recommended for PK/PD) | CEB-BY31 | 200ug |
| Anti-Bevacizumab Antibodies (AY9) (recommended for ADA assay) | BEB-Y9 | 1mg |
| Anti-Bevacizumab Antibodies (AY12) (recommended for neutralizing assay) | BEB-Y12 | 1mg |
| Anti-Adalimumab Antibodies (AY19) | ADB-Y19 | 1mg |
| Anti-Cetuximab Antibodies (AY31) (Non-Neutralizing) | CEB-Y31 | 1mg |
| GMP Monoclonal Anti-Human CD3 Antibody (OKT3) DMF Filed | GMP-MC0323 | 500ug |
| Monoclonal Anti-Human CD3 Antibody, Mouse IgG2a (Clone: OKT3), premium grade | CDE-M120a | 1mg |
| APC-Labeled Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (Site-specific conjugation) | FM3-AY54P1 | 200tests |
| PE-Labeled Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (Site-specific conjugation) DMF Filed (0.03% Proclin) | FM3-PY54A2 | 200tests |
| FITC-Labeled Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (HEK293) | FM3-FY45P1 | 200tests |
| Biotinylated Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1, Avitag™ (Y45) DMF Filed | FM3-BY54 | 200tests |
| PE-Labeled Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (Site-specific conjugation) DMF Filed (Preservative free) | FM3-HPY53 | 200tests |
| Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (HEK293) DMF Filed | FM3-Y45P1 | 1000tests |
| FITC-Labeled Anti-Rituximab Antibodies, Mouse IgG1 | RIB-FY35c | 200ug |
| FITC-Labeled Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) DMF Filed | FM3-FY45 | 200tests |
| Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) DMF Filed | FM3-Y45 | 1000tests |
| Biotinylated Anti-Human CD3 Antibody, Mouse IgG2a,Avitag™ (Clone: OKT3), premium grade | CDE-M525a | 50ug |
| Anti-Adalimumab Antibodies (AY23b) (recommended for PK/PD) | ADB-Y23b | 100ug |
| Rabbit Anti-Mouse FMC63 scFv Polyclonal Antibody (recommended for ADA assay) (MALS verified) | FM3-S93 | 1mg |
| Anti-Trastuzumab Antibodies (AY1b) (recommended for PK/PD) | TRB-Y1b | 100ug |
| Anti-Trastuzumab Antibodies (AY1b) (recommended for PK/PD) | TRB-Y1b | 1mg |
| Anti-Rituximab Antibodies (MALS verified) | RIB-Y35c | 100ug |
| Anti-Rituximab Antibodies (MALS verified) | RIB-Y35c | 1mg |
| Anti-Adalimumab Antibodies (AY23b) (recommended for PK/PD) | ADB-Y23b | 1mg |
| Anti-Trastuzumab Antibodies (recommended for PK/PD) | TRB-Y1 | 100ug |
| Anti-Trastuzumab Antibodies (recommended for PK/PD) | TRB-Y1 | 1mg |
| Anti-Bevacizumab Antibodies (AY10) (MALS verified, recommended for PK/PD) | BEB-Y10 | 1mg |
| Biotinylated Anti-Bevacizumab Antibodies (AY13) (recommended for PK/PD) | BEB-BY13 | 25ug |
| Biotinylated Anti-Bevacizumab Antibodies (AY13) (recommended for PK/PD) | BEB-BY13 | 200ug |
| Anti-Trastuzumab Antibodies (AY5b) (recommended for PK/PD) | TRB-Y5b | 100ug |
| Anti-Trastuzumab Antibodies (AY5b) (recommended for PK/PD) | TRB-Y5b | 1mg |
| Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (Carrier-free) (recommended for ADA assay) DMF Filed | FM3-Y45A1 | 25ug |
| Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (Carrier-free) (recommended for ADA assay) DMF Filed | FM3-Y45A1 | 100ug |
| Monoclonal Anti-FMC63 scFv Antibody, Mouse IgG1 (Y45) (Carrier-free) (recommended for ADA assay) DMF Filed | FM3-Y45A1 | 1mg |
| Rabbit Anti-Mouse FMC63 scFv Polyclonal Antibody (recommended for ADA assay) (MALS verified) | FM3-S93 | 100ug |
| Anti-Rituximab Antibodies (AY36) (recommended for ADA assay) | RIB-Y36 | 1mg |
| Anti-Rituximab Antibodies (AY37) (recommended for PK/PD) | RIB-Y37 | 100ug |
| Anti-Rituximab Antibodies (AY37) (recommended for PK/PD) | RIB-Y37 | 1mg |
| Anti-Rituximab Antibodies (AY36) (recommended for ADA assay) | RIB-Y36 | 100ug |
| Anti-Rituximab Antibodies | RIB-Y35 | 1mg |
| Anti-Rituximab Antibodies | RIB-Y35 | 100ug |
| Anti-Cetuximab Antibodies (AY29) (recommended for PK/PD) | CEB-Y29 | 1mg |
| Biotinylated Anti-Cetuximab Antibodies (AY31) (recommended for PK/PD) | CEB-BY31 | 25ug |
| Anti-Cetuximab Antibodies (AY31) (Non-Neutralizing) | CEB-Y31 | 100ug |
| Anti-Cetuximab Antibodies (AY31) (Non-Neutralizing) | CEB-Y31 | 1mg |
| Anti-Adalimumab Antibodies (AY19) | ADB-Y19 | 100ug |
| Anti-Adalimumab Antibodies (AY19) | ADB-Y19 | 1mg |
| Anti-Bevacizumab Antibodies (AY10) (MALS verified, recommended for PK/PD) | BEB-Y10 | 100ug |
| Anti-Bevacizumab Antibodies (AY12) (recommended for neutralizing assay) | BEB-Y12 | 100ug |
| Anti-Bevacizumab Antibodies (AY12) (recommended for neutralizing assay) | BEB-Y12 | 1mg |
| Anti-Bevacizumab Antibodies (AY9) (recommended for ADA assay) | BEB-Y9 | 100ug |
